Invasive vs conservative management in elderly patients with NSTEMI- insights from the SENIOR-RITA trial

Area of Science:

• Cardiology
• Geriatric Medicine
• Clinical Trials

Background:

• Elderly patients with Non-ST-segment elevation myocardial infarction (NSTEMI) represent a complex subgroup requiring careful treatment strategy evaluation.
• The SENIOR-RITA trial aimed to compare invasive versus conservative management approaches in this population.

Purpose of the Study:

• To evaluate the long-term efficacy and safety of an early invasive strategy compared to a conservative approach in elderly patients with NSTEMI.
• To determine the optimal management strategy for older adults experiencing NSTEMI.

Main Methods:

• Randomized 1,518 elderly patients with NSTEMI into either an invasive or a conservative treatment arm.
• Assessed the primary composite outcome of cardiovascular death or nonfatal Myocardial Infarction (MI) at 5 years.
• Monitored procedural complications, bleeding rates, and Transient Ischemic Attack (TIA) incidence.

Main Results:

• The primary composite outcome occurred in 25.6% of the invasive group versus 26.3% in the conservative group (p=0.53) at 5 years.
• The invasive strategy showed a trend towards lower nonfatal MI rates (11.7% vs 15.0%) but was associated with slightly higher bleeding and TIA rates.
• An early 1-year benefit observed with the invasive approach was not sustained at the 5-year follow-up.

Conclusions:

• For elderly NSTEMI patients, an early invasive strategy does not offer a significant long-term advantage over a conservative approach regarding the primary composite outcome.
• Individualized management is crucial for this complex elderly population, considering potential risks and benefits.
• The SENIOR-RITA trial provides valuable insights into the long-term outcomes of different treatment strategies in older NSTEMI patients.